Endothelin receptor antagonists for pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Endothelin receptor antagonists for pulmonary arterial hypertension

Published:2013-02-28 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Liu Chao¹,Chen Junmin²,Gao Yanqiu¹,Deng Bao¹,Liu Kunshen¹

Affiliation:

1. The First Hospital of Hebei Medical University; Donggang Road Shijiazhuang Hebei Province China 050031

2. The First Affiliated Hospital of Fujian Medical University; Department of Hematology and Rheumatology; #20 Chazhong Road Fuzhou Fujian Province China 350005

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004434.pub5/fullpdf

Reference123 articles.

1. US Food and Drug Administration. Center for drug evaluation and research. Letairis (Ambrisentan) Tablets: Medical Review(s) http://www.fda.gov/cder/foi/nda/2007/022081s000TOC.htm (Accessed March 20, 2008)

2. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2;Galiè;Circulation,2008

3. US Food and Drug Administration. Center for drug evaluation and research. Letairis (Ambrisentan) Tablets: Medical Review(s) http://www.fda.gov/cder/foi/nda/2007/022081s000TOC.htm (Accessed March 20, 2008)

4. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2;Galiè;Circulation,2008

5. Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies;Barst;British Journal of Haematology,2010

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension;Cochrane Database of Systematic Reviews;2024-01-22

2. Immunosuppression for the treatment of pulmonary hypertension in patients with systemic lupus erythematosus: A systematic review;International Journal of Rheumatic Diseases;2023-05-04

3. The potential benefit of endothelin receptor antagonists’ therapy in idiopathic pulmonary fibrosis: A meta-analysis of results from randomized controlled trials;Medicine;2022-10-07

4. Synthesizing evidence from the earliest studies to support decision‐making: To what extent could the evidence be reliable?;Research Synthesis Methods;2022-07-16

5. Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review;Biomedicine & Pharmacotherapy;2022-07